{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The purpose of the present study was to determine whether chronic administration of temocapril , a long - acting non - SH group angiotensin converting enzyme ( ACE ) inhibitor , reduced proteinuria , inhibited glomerular hypertrophy and prevented glomerulosclerosis in chronic puromycin aminonucleoside ( PAN ) - induced nephrotic rats .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic puromycin aminonucleoside ( PAN )-induced nephrotic syndrome |\n| glomerulosclerosis |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic puromycin aminonucleoside ( PAN)-induced nephrotic syndrome |\n| glomerulosclerosis |"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The purpose of the present study was to determine whether chronic administration of temocapril , a long - acting non - SH group angiotensin converting enzyme ( ACE ) inhibitor , reduced proteinuria , inhibited glomerular hypertrophy and prevented glomerulosclerosis in chronic puromycin aminonucleoside ( PAN ) - induced nephrotic rats .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temocapril |\n| long-acting non-SH group angiotensin converting enzyme (ACE) inhibitor |\n| chronic puromycin aminonucleoside (PAN) |\n| puromycin aminonucleotide (the active metabolite of puromycin aminonucleoside) |\n| angiotensin converting enzyme (ACE) |\n| SH group (sulfhydryl group) |\n| glomerulosclerosis |\n| proteinuria |\n\nNote: Glomerulosclerosis and proteinuria are not chemicals but conditions or outcomes. However, they are often associated with specific chemical causes or markers, so they are included for completeness."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temocapril |\n| long-acting non-SH group angiotensin converting enzyme (ACE) inhibitor |\n| puromycin aminonucleoside (PAN) |\n| angiotensin converting enzyme (ACE) |\n\nNote: Proteinuria and glomerulosclerosis are not chemicals, but conditions or outcomes. They are not mentioned as specific chemicals in the paragraph."}
  ]
}